FDA Warns J&J It Can't Slip Away From K-Y Complaints

Law360, New York (May 29, 2012, 8:46 PM EDT) -- A Johnson & Johnson unit has failed to adequately respond to some of the over 200 complaints it has received about its K-Y vaginal moisturizer products, according to a U.S. Food and Drug Administration warning letter made public Tuesday.

In a letter dated May 22, the FDA warned McNeil-PPC Inc. that a winter inspection of the pharmaceutical company had revealed that the manufacturing, packing and storage of several of its K-Y products, as well as tampons, floss and eye drops, did not conform with manufacturing practice...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.